Management of Crohn Disease

医学 疾病 克罗恩病 英夫利昔单抗 不利影响 免疫学 内科学 炎症性肠病
作者
Kelly C. Cushing,Peter Higgins
出处
期刊:JAMA [American Medical Association]
卷期号:325 (1): 69-69 被引量:149
标识
DOI:10.1001/jama.2020.18936
摘要

Importance

Crohn disease, a chronic gastrointestinal inflammatory disease, is increasing in incidence and prevalence in many parts of the world. Uncontrolled inflammation leads to long-term complications, including fibrotic strictures, enteric fistulae, and intestinal neoplasia. Therefore, early and effective control of inflammation is of critical importance.

Observations

The optimal management approach for Crohn disease incorporates patient risk stratification, patient preference, and clinical factors in therapeutic decision-making. First-line therapy generally consists of steroids for rapid palliation of symptoms during initiation of anti–tumor necrosis factor α therapy. Other treatments may include monoclonal antibodies to IL-12/23 or integrin α4β7, immunomodulators, combination therapies, or surgery. Effective control of inflammation reduces the risk of penetrating complications (such as intra-abdominal abscesses and fistulae), although more than half of patients will develop complications that require surgery. Adverse reactions to therapy include antibody formation and infusion reactions, infections, and cancers associated with immune modulators and biologics and toxicity to the bone marrow and the liver. Both Crohn disease and corticosteroid use are associated with osteoporosis. Vaccinations to prevent infections, such as influenza, pneumonia, and herpes zoster, are important components of health maintenance for patients with Crohn disease, although live vaccines are contraindicated for patients receiving immune suppression therapy.

Conclusions and Relevance

The treatment of patients with Crohn disease depends on disease severity, patient risk stratification, patient preference, and clinical factors, including age of onset and penetrating complications, and includes treatment with steroids, monoclonal antibody therapies, immunomodulators, and surgery. Physicians should be familiar with the advantages and disadvantages of each therapy to best counsel their patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI2S应助科研通管家采纳,获得10
刚刚
情怀应助科研通管家采纳,获得10
刚刚
SciGPT应助科研通管家采纳,获得10
刚刚
orixero应助彩色觅柔采纳,获得10
刚刚
orixero应助科研通管家采纳,获得10
刚刚
糯米糍完成签到,获得积分10
刚刚
1秒前
情怀应助1场久下未停的雨采纳,获得10
1秒前
不找了完成签到,获得积分10
2秒前
隐形曼青应助张同学采纳,获得10
2秒前
嘟嘟完成签到 ,获得积分10
2秒前
2秒前
ttw发布了新的文献求助10
4秒前
脑洞疼应助星空_采纳,获得20
4秒前
4秒前
4秒前
5秒前
5秒前
serein应助外向钢笔采纳,获得10
5秒前
5秒前
研友_8K2QJZ完成签到,获得积分0
5秒前
weslywang发布了新的文献求助10
5秒前
ZZZZZ完成签到,获得积分10
5秒前
Delire完成签到,获得积分10
6秒前
Matrix完成签到,获得积分10
6秒前
6秒前
7秒前
7秒前
8秒前
9秒前
我在青年湖旁完成签到,获得积分10
9秒前
迷你的隶完成签到,获得积分10
9秒前
张三发布了新的文献求助10
9秒前
10秒前
小白又鹏发布了新的文献求助10
10秒前
10秒前
光亮天抒发布了新的文献求助10
10秒前
神勇的长颈鹿完成签到 ,获得积分10
11秒前
11秒前
12秒前
高分求助中
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Bayesian Models of Cognition:Reverse Engineering the Mind 888
Le dégorgement réflexe des Acridiens 800
Defense against predation 800
Very-high-order BVD Schemes Using β-variable THINC Method 568
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3134700
求助须知:如何正确求助?哪些是违规求助? 2785629
关于积分的说明 7773333
捐赠科研通 2441325
什么是DOI,文献DOI怎么找? 1297881
科研通“疑难数据库(出版商)”最低求助积分说明 625070
版权声明 600825